You are here
Link Between Mesothelin Antibody, Ovarian Cancer and Infertility Identified
A blood molecule has been identified that could help doctors spot the very earliest signs of ovarian cancer and prevent thousands of deaths. Discovering the new biomarker, an antibody forming part of the immune system, could pave the way to screening women at high risk of ovarian cancer or those with early-stage tumours, say researchers from the University of Chicago. They investigated what molecules women with a risk of ovarian cancer and those with ovarian cancer had in common and found a a link between the mesothelin antibody, infertility, and ovarian cancer. A strong association between infertility and the disease was already known from previous studies..